AGIO — Agios Pharmaceuticals, Inc.
Healthcare • Biotechnology
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND...…
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $27.73
- Day High
- $28.58
- Day Low
- $27.51
- 52w High
- $57.33
- 52w Low
- $22.24
- Volume
- 409,829
- Avg Volume
- Beta
- 0.865
* TTM/most recent where available
Company
- Ticker
- AGIO
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Brian Goff
- Employees
- 486
- Website
- www.agios.com
Key Metrics
- Market Cap
- 1.63B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).